Bostal, LLC
Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees
AustarPharma, LLC is an emerging and innovative pharmaceutical company with focus on the drug delivery and generic drug products.
Innovative Product Focus AustarPharma specializes in drug delivery and generic pharmaceuticals, presenting opportunities to provide advanced manufacturing solutions, formulation services, or technology platforms that enhance product efficacy and speed to market.
Mid-Size Growth Potential With revenue between 25 and 50 million dollars and a growing team, the company is likely seeking scalable manufacturing, distribution, and regulatory consulting services to support its expansion efforts.
Technology Utilization The company's diverse tech stack indicates an openness to digital and automation solutions, such as ERP systems, cloud-based integrations, or IT infrastructure enhancements to streamline operations.
Location Strategic Based in Edison, New Jersey, AustarPharma is positioned in a major pharmaceutical hub, providing opportunities to offer supply chain, logistics, or proximity-based manufacturing collaborations.
Market Growth Potential Operating within the rapidly expanding pharmaceutical sector with competitors like Lonza and Thermo Fisher signals a high-growth environment, ideal for proposing innovative formulations, contract manufacturing, or R&D partnerships.
Bostal, LLC uses 8 technology products and services including Sage 50, Google Fonts API, Microsoft, and more. Explore Bostal, LLC's tech stack below.
| Bostal, LLC Email Formats | Percentage |
| First.Last@austarpharma.com | 49% |
| FLast@austarpharma.com | 1% |
| First@austarpharma.com | 1% |
| First.Last@austarpharma.com | 49% |
Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees
AustarPharma, LLC is an emerging and innovative pharmaceutical company with focus on the drug delivery and generic drug products.
Bostal, LLC's revenue is estimated to be in the range of $25M$50M
Bostal, LLC's revenue is estimated to be in the range of $25M$50M